Cellnovo Group (“Cellnovo” CLNV:EN Paris), a medical technology company marketing the first mobile, connected, all-in-one diabetes management system, today announces its revenue from sales and cash position at December 31, 2015. Over the fourth quarter of 2015, Cellnovo booked record sales of €346,524, an almost four-fold increase over the fourth quarter of 2014. For the full year 2015, revenues totaled €608,125, an almost five-fold increase over 2014.